FDA's Horowitz Encourages Industry to Participate in Supply Chain Pilots
This article was originally published in The Gold Sheet
Get involved in supply chain pilots urges FDA's Horowitz in remarks at Georgia GMP conference. As imports grow, FDA is responding with 'paradigm shift.' Secure supply chain pilot program described. Industry responds with call for greater flexibility. Third-party food certification program launched. Draft guidance proposes good importer practices. Drug makers respond with 'Green Lane' proposal. New authorities in Globalization Act described.
You may also be interested in...
While COVID-19 continues to wreak havoc on FDA's ability to perform onsite preapproval inspections, new guidance offers some clarity, but the news isn't great for ANDA holders.
The WHO proposes to revise 2011 guidance on technology transfers to ease the hand-off of COVID-19 drugs and vaccines from research and development facilities to commercial sites.
Two groups have issued largely complementary testing methods for measuring nitrosamine impurities in drugs, and the differences that do exist are “insignificant,” EDQM official advises. The two are working to further harmonize testing standards, given the global scope of the nitrosamine scare.